NEA Management Company’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-430,252
| Closed | -$1.29M | – | 45 |
|
|
2023
Q4 | $1.29M | Hold |
430,252
| – | – | 0.09% | 40 |
|
|
2023
Q3 | $4.11M | Sell |
430,252
-51,425
| -11% | -$492K | 0.32% | 35 |
|
|
2023
Q2 | $6.24M | Hold |
481,677
| – | – | 0.48% | 32 |
|
|
2023
Q1 | $4.89M | Hold |
481,677
| – | – | 0.34% | 37 |
|
|
2022
Q4 | $4.44M | Buy |
+481,677
| New | +$4.44M | 0.25% | 40 |
|